A coroner hears that the pilot of a helicopter used for theme-park scenic flights was likely mildly impaired by cocaine, alongside alcohol use and limited sleep in the days before a fatal midair collision, according to multiple reports. The inquest considers evidence relating to the pilot’s condition prior to the crash in which tourists were aboard during the scenic flight. One report says the pilot may not have appreciated the level of impairment from drug and alcohol use before the accident. The accounts describe the coroner’s assessment as “likely mildly impaired,” rather than concluding severe impairment. The evidence referenced in the reporting focuses on suspected drug use and factors affecting alertness, including alcohol and little sleep over the preceding days. The pilot’s impairment is presented as a coroner’s finding heard during the inquest process, with the reports reflecting the same overall theme: that cocaine, alcohol and insufficient rest likely contributed to how the pilot was functioning before the crash. The fatal midair collision forms the central incident being investigated.
Coroner hears Sea World scenic flight pilot likely mildly impaired by cocaine
Key Points
- A coroner hears the helicopter pilot was likely mildly impaired before a fatal midair collision during a theme-park scenic flight.
- The reports cite cocaine as one factor in the pilot’s likely impairment.
- Alcohol use is also described as a contributing factor in the days before the crash.
- The coroner hears the pilot had little sleep in the days prior to the incident.
- One report says the pilot may not have realised the impairment from drug and alcohol use before the accident.
4 sources
3 months ago
39 views
This summary is generated automatically from the reporting of the outlets listed on this page. Follow their links for the full coverage.
How Outlets Covered This Story
BRI
THE
THE
PER
Related Stories
AI-wearable approach may flag hypertensive crisis up to three days ahead
Researchers report preliminary findings that combining wrist-worn wearable measurements with AI analysis could help iden...
2 sources
5 hours ago
NHS England lists 29 Palantir-benefiting trusts while some report little or no use
NHS England publicly lists 29 hospital trusts as “realising benefits” from Palantir’s federated data platform, but multi...
2 sources
4 hours ago
US FDA approves generic lenacapavir, a twice-yearly HIV prevention injection
The US Food and Drug Administration (FDA) approves a generic version of lenacapavir, a twice-yearly injection used to pr...
4 sources
1 hour ago